Dolor Technologies
About:
Dolor Technologies provides a drug delivery system to deliver medication to the area of sphenopalatine ganglion.
Website: http://sphenocath.com
Twitter/X: sphenocath
Description:
Dolor Technologies provides a drug delivery system to deliver medication to the area of the sphenopalatine ganglion. It was established in 2010 and is based in South Jordan, Utah.
Total Funding Amount:
$800000
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
South Jordan, Utah, United States
Founded Date:
2010-01-01
Contact Email:
info(AT)sphenocath.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2014-01-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai